Home » TRESTLE SUBMITS 510(K) APPLICATION TO FDA FOR DIGITAL PATHOLOGY WHOLE-SLIDE IMAGING SYSTEM AS A CLASS II DEVICE
TRESTLE SUBMITS 510(K) APPLICATION TO FDA FOR DIGITAL PATHOLOGY WHOLE-SLIDE IMAGING SYSTEM AS A CLASS II DEVICE
Trestle Holdings Inc., a major supplier of digital imaging systems and services
for use in clinical pathology, drug safety and discovery, has submitted a pre-market
notification or 510(k) with the US Food and Drug Administration (FDA) for clearance
of its digital pathology whole-slide imaging System as a Class II device.
Yahoo News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May